Antithrombin III activity is associated with prognosis, infection, and inflammation in patients with hepatitis B virus-related acute-on-chronic liver failure.

Xueshi ZhouXinyue ChenHejuan DuYangqun YeYouhan MiuTingting SuXiaoye GuoSen WangYuanwang QiuJun WangWeifeng Zhao

Published in: European journal of gastroenterology & hepatology (2023)

As a natural anticoagulant, antithrombin Ⅲ can be regarded as a marker of inflammation and infection in patients with HBV-ACLF, and as a predictor of survival outcome in patients with ACLF.

Keyphrases

liver failure
hepatitis b virus
oxidative stress
atrial fibrillation
venous thromboembolism
drug induced
free survival